Literature DB >> 6192173

Synthetic vaccines.

R Arnon, M Shapira, C O Jacob.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6192173     DOI： 10.1016/0022-1759(83)90220-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  13 in total

1.  Adjuvanted outer membrane protein vaccine protects poultry against infection with Salmonella enteritidis.

Authors:  M Meenakshi; C S Bakshi; G Butchaiah; M P Bansal; M Z Siddiqui; V P Singh
Journal:  Vet Res Commun       Date:  1999-03       Impact factor: 2.459

2.  Prediction of optimal peptide mixtures to induce broadly neutralizing antibodies to human immunodeficiency virus type 1.

Authors:  L H Holley; J Goudsmit; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein.

Authors:  M Sabara; J E Gilchrist; G R Hudson; L A Babiuk
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.

Authors:  C O Jacob; M Sela; M Pines; S Hurwitz; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.

Authors:  R Glück; R Mischler; S Brantschen; M Just; B Althaus; S J Cryz
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  Synthetic sulpholipopolysaccharides: novel adjuvants for humoral immune responses.

Authors:  L A Hilgers; H Snippe; M Jansze; J M Willers
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

7.  Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.

Authors:  M Shapira; M Jibson; G Muller; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.

Authors:  C O Jacob; M Leitner; A Zamir; D Salomon; R Arnon
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

9.  A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody.

Authors:  Y M Thanavala; S E Brown; C R Howard; I M Roitt; M W Steward
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Induction of anti-HIV neutralizing antibodies by synthetic peptides.

Authors:  T C Chanh; G R Dreesman; P Kanda; G P Linette; J T Sparrow; D D Ho; R C Kennedy
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.